| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |